Skip to content

Clinical trials

Alagille Syndrome trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Alagille Syndrome Clear all

31 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20072
20101
20133
20143
20151
20162
20171
20214
20221
20233
20252
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Recruiting10
Active, not recruiting1
Approved for marketing1
Suspended1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Mirum Pharmaceuticals, Inc.10
Albireo3
Arbor Research Collaborative for Health2
Ipsen2
Stanford University2
Takeda2
Albireo, an Ipsen Company1
Asociación Española para el Estudio del Hígado1
Children's Hospital of Eastern Ontario1
Children's Hospital of Fudan University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Alagille Syndrome31
Cholestasis6
Liver Diseases5
Biliary Atresia4
Liver Cirrhosis, Biliary4
Bile Duct Diseases2
Biliary Tract Diseases2
Genetic Diseases, Inborn2
Pruritus2
Rare Diseases2

Trials

Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.